IMU.AX
Price:
$0.043
Market Cap:
$319.85M
Imugene Limited, a clinical stage immuno-oncology company, develops a range of immunotherapies to activate the immune system of cancer patients to treat and eradicate tumors in Australia. Its lead product is HER-Vaxx, a HER2-positive cancer vaccine that stimulates a polyclonal antibody response against HER2/neu receptors in gastric and breast cancer. The company's HER-Vaxx is in Phase 1b/2 study for gastric cancer. It also engages in developing PD1-Vaxx, a cancer vaccine that aims to induce the body to produce polyclonal antibodies that block PD-1 signalling; and CF33, a combination of genomic sequences from various vaccinia virus strains to generate potent virus. The company has a research ...[Read more]
Industry
Biotechnology
IPO Date
1998-12-31
Stock Exchange
ASX
Ticker
IMU.AX
According to Imugene Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 228.29M. This represents a change of -56.31% compared to the average of 522.47M of the last 4 quarters.
The mean historical Enterprise Value of Imugene Limited over the last ten years is 350.25M. The current 228.29M Enterprise Value has changed 6.42% with respect to the historical average. Over the past ten years (40 quarters), IMU.AX's Enterprise Value was at its highest in in the December 2021 quarter at 2.06B. The Enterprise Value was at its lowest in in the March 2009 quarter at 0.
Average
350.25M
Median
82.48M
Minimum
8.98M
Maximum
1.63B
Discovering the peaks and valleys of Imugene Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.59%
Maximum Annual Enterprise Value = 1.63B
Minimum Annual Increase = -54.29%
Minimum Annual Enterprise Value = 8.98M
Year | Enterprise Value | Change |
---|---|---|
2024 | 298.32M | -28.71% |
2023 | 418.49M | -54.29% |
2022 | 915.48M | -43.71% |
2021 | 1.63B | 1.59% |
2020 | 96.28M | 176.65% |
2019 | 34.80M | -49.32% |
2018 | 68.68M | 184.37% |
2017 | 24.15M | 168.85% |
2016 | 8.98M | -18.22% |
2015 | 10.98M | 41.98% |
The current Enterprise Value of Imugene Limited (IMU.AX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
544.10M
5-year avg
670.98M
10-year avg
350.25M
Imugene Limited’s Enterprise Value is less than BrainChip Holdings Ltd (392.21M), less than Mesoblast Limited (2.04B), greater than Lake Resources NL (48.96M), less than Immutep Limited (350.88M), less than PolyNovo Limited (1.41B),
Company | Enterprise Value | Market cap |
---|---|---|
392.21M | $658.29M | |
2.04B | $3.22B | |
48.96M | $69.49M | |
350.88M | $473.07M | |
1.41B | $1.44B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Imugene Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Imugene Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Imugene Limited's Enterprise Value?
What is the highest Enterprise Value for Imugene Limited (IMU.AX)?
What is the 3-year average Enterprise Value for Imugene Limited (IMU.AX)?
What is the 5-year average Enterprise Value for Imugene Limited (IMU.AX)?
How does the current Enterprise Value for Imugene Limited (IMU.AX) compare to its historical average?